E-LIB Suche - Ergebnisse für: Tandstad, T.

1

Low rate of teratoma in primary retroperitoneal lymph node ..:

Gerdtsson, A. ; Thor, A.T. ; Grenabo Bergdahl, A.G.B....
European Urology. 83 (2023) - p. S1072 , 2023

Link: https://doi.org/10.1016/..

2

PO-1468 Influence of PSMA-PET on treatment of prostate canc..:

Knudtsen, I.S. ; Abrahamsen, B.S. ; Selnæs, K.M....
Radiotherapy and Oncology. 182 (2023) - p. S1189-S1190 , 2023

Link: https://doi.org/10.1016/..

3

The early results of the SWENOTECA (Swedish Norwegian Testi..:

Thor, A. ; Grenabo Bergdahl, A. ; Almas, B....
European Urology. 83 (2023) - p. S1068 , 2023

Link: https://doi.org/10.1016/..

4

Location and histology of retroperitoneal metastases in pos..:

Gerdtsson, A. ; Thor, A. ; Grenabo, A....
European Urology Open Science. 19 (2020) - p. e395-e396 , 2020

Link: https://doi.org/10.1016/..

5

Current clinical management of relapsed testicular cancer, ..:

Tandstad, T.
European Urology Supplements. 18 (2019) 4 - p. 29 , 2019

Link: https://doi.org/10.1016/..

6

2601 Outcome of relapses after adjuvant carboplatin in clin..:

Fischer, S. ; Tandstad, T. ; Weather, M....
European Journal of Cancer. 51 (2015) - p. S511-S512 , 2015

Link: https://doi.org/10.1016/..

7

Surveillance vs. adjuvant therapy of clinical stage I testi..:

Cohn‐Cedermark, G. ; Stahl, O. ; Tandstad, T..
Andrology. 3 (2014) 1 - p. 102-110 , 2014

Link: https://doi.org/10.1111/..

8

4512 POSTER Risk-adapted treatment in clinical stage 1 (CS1..:

Tandstad, T. ; Dahl, O. ; Cohn Cedermark, G....
European Journal of Cancer Supplements. 5 (2007) 4 - p. 302 , 2007

Link: https://doi.org/10.1016/..

9

Survival and New Prognosticators in Metastatic Seminoma: Re..:

Beyer, J ; Collette, L ; Sauvé, N...
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2021, pp. JCO2003292 - ?. , 2021

Link: https://repository.icr.a..

10

Survival and New Prognosticators in Metastatic Seminoma: Re..:

Beyer, J ; Collette, L ; Sauvé, N...
https://eprints.whiterose.ac.uk/172708/1/2021%20JCO%20Article%20Beyer%20Seminoma%20Prognosis%20%283%29.pdf. , 2021

Link: https://eprints.whiteros..

11

Survival and New Prognosticators in Metastatic Seminoma: Re..:

Beyer, J ; Collette, L ; Sauve, N...
issn:0732-183X. , 2021

Link: http://hdl.handle.net/11..

12

Predicting Outcomes in Men With Metastatic Nonseminomatous ..:

Gillessen, S ; Sauvé, N ; Collette, L...
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2021, 39 (14), pp. 1563 - 1574. , 2021

Link: https://repository.icr.a..

13

Predicting Outcomes in Men With Metastatic Nonseminomatous ..:

Gillessen, S ; Sauvé, N ; Collette, L...
https://discovery.ucl.ac.uk/id/eprint/10126271/1/jco.20.03296.pdf. , 2021

Link: https://discovery.ucl.ac..

14

Survival and New Prognosticators in Metastatic Seminoma: Re..:

Beyer, J ; Collette, L ; Sauvé, N...
https://discovery.ucl.ac.uk/id/eprint/10124779/1/jco.20.03292.pdf. , 2021

Link: https://discovery.ucl.ac..

15

Maintaining success, reducing treatment burden, focusing on..:

Beyer, J ; Albers, P ; Altena, R...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603440. , 2013

Link: http://www.ncbi.nlm.nih...